Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor (2020) Michal M, Rubin BP, Kazakov DV, Michalová K, Šteiner P, Grossmann P, Hájková V, et al. Journal article What is new in epithelioid soft tissue tumors? (2019) Agaimy A Journal article, Review article Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma (2019) Weyerer V, Weisser R, Moskalev E, Haller F, Stoehr R, Eckstein M, Zinnall U, et al. Journal article Tumour mutational burden analysis: implementation in routine diagnostics (2019) Kroeze L, Kamping E, Von Rhein D, Jansen E, De Voer R, Barberis M, Botling J, et al. Conference contribution Large nested variant of urothelial carcinoma: a prime example of a FGFR3-mutated, luminal tumour (2019) Weyerer V, Eckstein M, Comperat E, Juette H, Allory Y, Stoehr R, Wullich B, et al. Conference contribution Tumour immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes (2019) Eckstein M, Strissel P, Pfannstiel C, Chiappinelli K, Sikic D, Wach S, Taubert H, et al. Conference contribution MUC4 as a potential marker for differentiating MASC and PLGA in minor salivary glands (2019) Taverna C, Franchi A, Santucci M, Baneckova M, Skalova A, Agaimy A Conference contribution Glomerular disease associated with myeloproliferative and myelodysplastic/myeloproliferative neoplams (2019) Büttner-Herold M, Sticht C, Wiech T, Porubsky S Conference contribution Frequency of GNAS mutation in intramuscular myxoma (2019) Erber R, Stöhr R, Haller F, Hartmann A, Agaimy A Conference contribution Immunohistochemical TP53 expression in atypical fibroxanthoma and their mimics (2019) Erber R, Hartmann A, Agaimy A Conference contribution